128 related articles for article (PubMed ID: 38380977)
21. Role of the (pseudo)halido ligand in ruthenium(II)
Biancalana L; Zanda E; Hadiji M; Zacchini S; Pratesi A; Pampaloni G; Dyson PJ; Marchetti F
Dalton Trans; 2021 Nov; 50(43):15760-15777. PubMed ID: 34704998
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, RNA-sequence and evaluation of anticancer efficacy of ruthenium(II) polypyridyl complexes toward HepG2 cells.
Hu H; Zhang H; Zhong R; Yang Y; Huang C; Chen J; Liang L; Chen Y; Liu Y
J Inorg Biochem; 2023 Jul; 244():112230. PubMed ID: 37084581
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization, molecular docking, RNA-sequence and anticancer efficacy evaluation in vitro of ruthenium(II) complexes on B16 cells.
Huang C; Zhang H; Yang Y; Liu H; Chen J; Wang Y; Liang L; Hu H; Liu Y
J Inorg Biochem; 2023 Oct; 247():112329. PubMed ID: 37478780
[TBL] [Abstract][Full Text] [Related]
24. Ru(II)-
Dorairaj DP; Haribabu J; Dharmasivam M; Malekshah RE; Mohamed Subarkhan MK; Echeverria C; Karvembu R
Inorg Chem; 2023 Jul; 62(30):11761-11774. PubMed ID: 37459067
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents.
Massai L; Fernández-Gallardo J; Guerri A; Arcangeli A; Pillozzi S; Contel M; Messori L
Dalton Trans; 2015 Jun; 44(24):11067-76. PubMed ID: 25996553
[TBL] [Abstract][Full Text] [Related]
26. Reactive oxygen species generation and mitochondrial dysfunction for the initiation of apoptotic cell death in human hepatocellular carcinoma HepG2 cells by a cyclic dipeptide Cyclo(-Pro-Tyr).
Karanam G; Arumugam MK
Mol Biol Rep; 2020 May; 47(5):3347-3359. PubMed ID: 32248385
[TBL] [Abstract][Full Text] [Related]
27. Effective and Selective Ru(II)-Arene Complexes Containing 4,4'-Substituted 2,2' Bipyridine Ligands Targeting Human Urinary Bladder Cancer Cells.
Muralisankar M; Chen JR; Haribabu J; Ke SC
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569273
[TBL] [Abstract][Full Text] [Related]
28. Solution equilibrium, structural and cytotoxicity studies on Ru(η
Dömötör O; Kiss MA; Gál GT; May NV; Spengler G; Nové M; Gašparović AČ; Frank É; Enyedy ÉA
J Inorg Biochem; 2020 Jan; 202():110883. PubMed ID: 31689626
[TBL] [Abstract][Full Text] [Related]
29. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.
Bhattacharyya S; Purkait K; Mukherjee A
Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907
[TBL] [Abstract][Full Text] [Related]
30. Ruthenium(II)-Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria-Targeted Apoptotic Cell Death.
Sahu G; Patra SA; Lima S; Das S; Görls H; Plass W; Dinda R
Chemistry; 2023 Mar; 29(18):e202202694. PubMed ID: 36598160
[TBL] [Abstract][Full Text] [Related]
31. New glycoconjugation strategies for Ruthenium(II) arene complexes via phosphane ligands and assessment of their antiproliferative activity.
Iacopini D; Vančo J; Di Pietro S; Bordoni V; Zacchini S; Marchetti F; Dvořák Z; Malina T; Biancalana L; Trávníček Z; Di Bussolo V
Bioorg Chem; 2022 Sep; 126():105901. PubMed ID: 35671646
[TBL] [Abstract][Full Text] [Related]
32.
Gopalakrishnan D; Saravanan S; Merckx R; Madan Kumar A; Khamrang T; Velusamy M; Vasanth K; Sunitha S; Hoogenboom R; Maji S; Ganeshpandian M
Dalton Trans; 2021 Jun; 50(23):8232-8242. PubMed ID: 34037018
[TBL] [Abstract][Full Text] [Related]
33. Ambrosin sesquiterpene lactone exerts selective and potent anticancer effects in drug-resistant human breast cancer cells (MDA-MB-231) through mitochondrial mediated apoptosis, ROS generation and targeting Akt/β-Catenin signaling pathway.
Fan S; Cui Y; Hu Z; Wang W; Jiang W; Xu H
J BUON; 2020; 25(5):2221-2227. PubMed ID: 33277839
[TBL] [Abstract][Full Text] [Related]
34. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.
Oliveira KM; Honorato J; Demidoff FC; Schultz MS; Netto CD; Cominetti MR; Correa RS; Batista AA
J Inorg Biochem; 2021 Jan; 214():111289. PubMed ID: 33137682
[TBL] [Abstract][Full Text] [Related]
35. Ru
Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and Structural Evaluation of Organo-Ruthenium Complexes with β-Diketonates.
Uršič M; Lipec T; Meden A; Turel I
Molecules; 2017 Feb; 22(2):. PubMed ID: 28230756
[TBL] [Abstract][Full Text] [Related]
37. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.
Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M
J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601
[TBL] [Abstract][Full Text] [Related]
38. Investigating the anticancer potential of 4-phenylthiazole derived Ru(II) and Os(II) metalacycles.
Getreuer P; Marretta L; Toyoglu E; Dömötör O; Hejl M; Prado-Roller A; Cseh K; Legin AA; Jakupec MA; Barone G; Terenzi A; Keppler BK; Kandioller W
Dalton Trans; 2024 Mar; 53(12):5567-5579. PubMed ID: 38426897
[TBL] [Abstract][Full Text] [Related]
39. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η
Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU
J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390
[TBL] [Abstract][Full Text] [Related]
40. Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol.
Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
Dalton Trans; 2019 Apr; 48(16):5352-5360. PubMed ID: 30942794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
